梯瓦制药

33.92
-0.39
-1.14%
TEVA
 34.35 34.35 602.49万股总市值 390.02亿
 33.72 0.52% 2.05亿市盈TTM 276.61
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
用户头像
梯瓦制药(TEVA)
02-09 19:05  
$梯瓦制药(TEVA)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001178913-26-000330  Act: 34  Size: 7 KB 网页链接
用户头像
梯瓦制药(TEVA)
02-03 22:05  
$梯瓦制药(TEVA)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-26-034532  Act: 34  Size: 21 MB 网页链接
用户头像
梯瓦制药(TEVA)
01-30 05:15  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-029329  Size: 6 KB 网页链接
用户头像
梯瓦制药(TEVA)
01-30 05:15  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-029337  Size: 5 KB 网页链接
用户头像
梯瓦制药(TEVA)
01-30 05:05  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-029300  Size: 8 KB 网页链接
用户头像
梯瓦制药(TEVA)
01-30 05:05  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-029306  Size: 5 KB 网页链接
用户头像
梯瓦制药(TEVA)
01-30 05:05  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-029312  Size: 5 KB 网页链接
用户头像
梯瓦制药(TEVA)
01-28 20:25  
$梯瓦制药(TEVA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001171843-26-000462  Act: 34  Size: 949 KB 网页链接
用户头像
梯瓦制药(TEVA)
01-12 19:05  
$梯瓦制药(TEVA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001171843-26-000174  Act: 34  Size: 244 KB 网页链接
用户头像
梯瓦制药(TEVA)
2025-12-19 05:05  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-324780  Size: 6 KB 网页链接
用户头像
梯瓦制药(TEVA)
2025-12-19 05:05  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-324789  Size: 5 KB 网页链接
用户头像
梯瓦制药(TEVA)
2025-12-13 05:25  
$梯瓦制药(TEVA)$ 144 Report of proposed sale of securities Accession Number: 0000902664-25-005281  Act: 33  Size: 6 KB 网页链接
用户头像
梯瓦制药(TEVA)
2025-12-12 05:35  
$梯瓦制药(TEVA)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001193125-25-316063  Act: 34  Size: 217 KB 网页链接
用户头像
梯瓦制药(TEVA)
2025-12-12 05:15  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-315923  Size: 10 KB 网页链接
用户头像
梯瓦制药(TEVA)
2025-12-12 05:15  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-315938  Size: 12 KB 网页链接
用户头像
梯瓦制药(TEVA)
2025-12-10 05:08  
$梯瓦制药(TEVA)$ 144 Report of proposed sale of securities Accession Number: 0001973379-25-000315  Act: 33  Size: 4 KB 网页链接
用户头像
梯瓦制药(TEVA)
2025-12-10 05:05  
$梯瓦制药(TEVA)$ 144 Report of proposed sale of securities Accession Number: 0001973379-25-000316  Act: 33  Size: 5 KB 网页链接
用户头像
梯瓦制药(TEVA)
2025-12-05 05:06  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-308057  Size: 7 KB 网页链接
用户头像
梯瓦制药(TEVA)
2025-12-02 05:06  
$梯瓦制药(TEVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-303849  Size: 6 KB 网页链接
用户头像
梯瓦制药(TEVA)
2025-11-27 05:05  
$梯瓦制药(TEVA)$ 144 Report of proposed sale of securities Accession Number: 0000902664-25-005163  Act: 33  Size: 6 KB 网页链接